Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5221_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
21 Мб
Скачать
18
Acute Necrotizing Encephalopathy
of Childhood
Rabporn Suntornlohanakul and E. Ann Yeh
Introduction
Infection- associated encephalopathies are conditions characterized by neurological dysfunction occurring in the context of infection, primarily viral infection, that can also be subsumed under general syndromal umbrellas such as acute disseminated encephalomyelitis, a syndrome occurring primarily in the pediatric age group in which post- or para- infectious multifocal central nervous system (CNS) magnetic resonance imaging (MRI) abnormalities are noted. Importantly, however, many CNS infection- related syndromes with highly specic clinical and radiological nd­ings have been described in recent years: this higher level of specicity may be im­portant in understanding therapeutic approaches and outcomes. Examples include acute necrotizing encephalopathy of childhood (ANEC), acute encephalopathy with biphasic seizures and late reduced diusion, and mild encephalitis/ encephalopathy with a reversible splenial lesion (Takanashi, 2009). ANEC is of particular interest, in that its associated MRI scans are characterized by a highly typical pattern, and spe­cic pathogens and genetic abnormalities have been described in association with a proportion of these cases. In this chapter, following an illustrative case of ANEC, we will review information on its denitions, epidemiology, pathophysiology, clinical– radiological manifestations, dierential diagnosis, treatment, and outcomes.
Case
A 10- year- old boy with a history of speech delay was brought to the hospital due to diculty walking, imbalance, blurred vision, and episodes of confusion and diso­rientation. Five days prior to admission, he experienced a fever and u- like symp­toms. His birth history was unremarkable, and he denied any recent travel or contact with sick individuals. His neurological exam was signicant for right cranial nerve VI palsy, nystagmus, dysmetria, and gait ataxia. MRI revealed an expansile high T2/ uid- attenuated inversion recovery lesion of the pons, extending into the medulla, the midbrain, and bilateral middle cerebellar peduncles (Figure 18.1).
Rabporn Suntornlohanakul and E. Ann Yeh, Acute Necrotizing Encephalopathy of Childhood Neuropsychiatric Medicine
© Oxford University Press 2024. DOI: 10.1093/ oso/ 9780192870414.003.0019
 Infectious Disease and Neurocognition
Figure 18.1 Axial fluid- attenuated inversion recovery imaging showing an expansile
hyperintensity of the pons (arrowheads).
Cerebrospinal uid (CSF) analysis showed a leukocyte count of 5 cells/ μL, a pro­tein level of 27 mg/ dL, and a glucose level of 4.7 mmol/ L. A nasopharyngeal swab was positive for inuenza B. Other laboratory results were unremarkable. Suspicions for inuenza- associated CNS abnormalities and a possible diagnosis of ANEC were raised. Genetic testing for ANEC was sent. He was treated with oseltamivir and re­ceived 5 days of intravenous pulse methylprednisolone. Although his clinical status improved signicantly, he continued to experience residual cognitive and behav­ioral problems. e follow- up MRI 5 months later showed interval evolution of the lesions (Figure 18.2). Genetic testing later revealed a pathogenic variant of the
Figure 18.2 Five- month follow- up magnetic resonance imaging (MRI). (a) Axial fluid- attenuated inversion recovery MRI showing linear T2 hyperintense areas of cavitation in the region of the claustrum bilaterally (arrowheads). (b) Axial T2 imaging showing interval evolution of the pons with few cystic areas (arrowheads).
Acute Necrotizing Encephalopathy of Childhood 281
RANBP2 gene, c.1754C>T (p.r585Met). His mother and younger sister were also found to carry this genetic mutation.
Definitions
e term “acute necrotizing encephalopathy of childhood (ANEC)” was rst introduced by a Japanese group in 1995 to describe children experiencing acute neurological symptoms with distinctive radiological and pathological ndings following inuenza infection (Mizuguchi et al., 1995). Currently, ANEC is de­ned as a rare neurological condition characterized by the acute onset of impaired consciousness, neurological decline, seizures, and varying degrees of hepatic dysfunction, with characteristic MRI ndings including multifocal brain lesions specically aecting the deep gray matter including the thalami bilaterally and symmetrically and the brainstem. Given the identication of genetic susceptibility linked to the RANBP2 mutation in familial and recurrent cases, the term “ANE1” was introduced to categorize familial or genetic cases (Neilson et al., 2009). Detailed diagnostic criteria for ANEC and ANE1 are provided in Table 18.1.
Table 18.1 Proposed diagnosis criteria for ANEC and ANE1
Syndrome Criteria for diagnosis
ANEC 1. Acute encephalopathy following viral febrile disease. Rapid deterioration in the
level of consciousness. Convulsions
2. No CSF pleocytosis. An increase in CSF protein is commonly observed
3. Computed tomography or magnetic resonance imaging evidence of symmetric, multifocal brain lesions. Involvement of the bilateral thalami. Lesions are also common in the cerebral periventricular white matter, internal capsule, putamen, upper brainstem tegmentum and cerebellar medulla. No involvement of other CNS regions
4. Elevation of serum aminotransferases of variable degrees. No increase in blood ammonia
5. Exclusion of resembling diseases
ANE1 1. Prior episodes of encephalopathy following fever, with or without ndings
of ANEC
2. Family history of ANEC or acute neurologic ndings following fever:
a. Need not be a rst- degree relative; “aected cousins” are common b. Terms used to describe relatives’ previous episodes: viral encephalitis,
aseptic meningitis, acute disseminated encephalomyelitis, para- infectious encephalopathy, and “non- classic” or “acute” Leigh syndrome
3. CNS imaging demonstrating additional characteristics lesions in any of the following structures:
a. Medial temporal lobes, insular cortices, claustra, external capsule b. Amygdalae, hippocampi, mammillary bodies c. Spinal cord
Note: criteria from Mizuguchi (1997) and Neilson (2010). Abbreviations: ANE1, acute necrotizing encephalopathy type 1; ANEC, acute necrotizing encephalopathy of child-
hood; CNS, central nervous system; CSF, cerebrospinal uid.
 Infectious Disease and Neurocognition
Epidemiology
e exact global incidence of ANEC remains elusive despite an increasing number of reported cases worldwide. Notably, a signicant portion of reported cases are from Asia, particularly Taiwan, China, and Japan. According to a national survey in Japan, ANEC accounted for 4.1 percent of acute encephalopathy cases between 2007 and 2010 and 2.8 percent in 2014– 2017 (Hoshino et al., 2016; Kasai et al., 2020). Beyond Asia, limited epidemiological studies have been undertaken. Two longitudinal studies on inuenza- related neurological symptoms have been published, one in the United Kingdom and another in Australia. e United Kingdom study (2013– 2015) examined neurological cases resulting from inuenza infection in both adults and children (n = 25), with 21 (84 percent) occurring in children. Among these cases, only four were diagnosed with ANEC (Goenka et al., 2014). In another longitudinal study of inuenza- associated neurological disease in Australia (2013– 2015), ANEC accounted for only three (5.6 percent) of 54 cases (Britton et al., 2017). ANEC pre­dominantly aects the pediatric population. In a retrospective single- center study conducted in China in 2021 that described inuenza- associated encephalopathy (IAE) and ANEC, a total of 30 ANEC cases were reported with 73.3 percent (22/
30) being under the age of 5 years (Song et al., 2021). No sex predilection has been reported.
Pathogenesis
Although ANEC can occur in other systemic viral infections, inuenza remains the most commonly reported pathogen. Due to the common co- occurrence of ANEC in patients with systemic viral infection, it was initially presumed to be a para­infectious disease. However, no viruses have been isolated from brain biopsies per­formed in this population, and viral detection in CSF is infrequent (Aksoy et al., 2021; Chatur et al., 2022; Ito et al., 1999; Mizuguchi et al., 1995). e most widely accepted proposed mechanism for ANEC is the “cytokine storm,” although the exact pathogenesis remains to be fully understood. Several studies have demonstrated a signicant elevation of serum interleukin (IL)- 1 beta, IL- 2, IL- 10, IL- 6, and tumor necrosis factor alpha (TNF- α) in ANEC cases associated with inuenza and human herpes virus- 6 (HHV- 6) infection (Ichiyama et al., 2003; Kansagra & Gallentine,
2011). Similarly, an elevation of serum IL- 6 and TNF- α was found in a 4- year- old girl with ANEC at the time of chikungunya virus infection (Tabarki et al., 2013). e nding of elevated serum cytokines in ANEC cases, regardless of the pathogen in­volved, suggests the important role of inammation in the clinical and radiological manifestations of the disease. Notably, a postmortem histological study revealed ex­travasation of plasma- like materials surrounding the vessels within thalamic lesions, reecting a disruption in the blood– brain barrier (Mizuguchi et al., 2002). is is
Acute Necrotizing Encephalopathy of Childhood 283
further supported by a study that noted the development of contrast enhancement without structural signal abnormalities before the emergence of bilateral thalamic hypodensity (Yoshida et al., 2013).
Genetics
In 2009, Neilson and colleagues rst reported genetic associations between familial and recurrent ANEC cases and a missense mutation in the RANBP2 gene (Neilson et al., 2009). e RANBP2 gene follows an autosomal dominant inheritance pattern with incomplete penetrance (Neilson et al., 2003). A study of families carrying this mutation demonstrated that 40 percent of individuals carrying the mutation devel­oped clinical symptoms associated with ANEC (Neilson et al., 2009). is gene en­codes the nuclear pore protein RAN binding protein 2, which plays various roles during the cell cycle, including facilitating protein transport, cell tracking, and mi­tochondrial function. However, the exact mechanism by which this mutation leads to ANEC pathogenesis remains incompletely understood.
ere are similarities in the clinical manifestations of individuals diagnosed with ANEC who carry the gene mutation and those who do not. In a study by Chatur and colleagues, no dierences in clinical manifestations were found between indi­viduals carrying the RANBP2 mutation and those without the mutation (Chatur et al., 2022). e most frequent dierence between the two groups was the presence of clinical relapses in RANBP2- positive individuals in comparison to no relapses in RANBP2- negative patients. is highlights the importance of a RANBP2 mutation in predicting the clinical course in ANEC cases (Chatur et al., 2022). Follow- up in this study, however, was limited: further studies with longer follow- up are needed to conrm the association between RANBP2 and clinical course.
Nevertheless, the risk of recurrence in RANBP2- positive individuals has been conrmed in other studies. Sarigecili and colleagues described nine RANBP2 gene positive patients in whom two of the nine (22 percent) had recurrent events (Sarigecili et al., 2023). In the study, one patient experienced three attacks in 3 consecutive years, while another had two attacks in 1 year (Sarigecili et al., 2023). Interestingly, the clinical spectrum associated with RANBP2 mutation may encom­pass other conditions such as polyneuritis or cranial nerve palsies, which have been found in family members who also carry the RANBP2 gene mutation (Gika et al.,
2010). e complex and overlapping relationships between the RANBP2 gene muta- tion, IAE, and ANEC are illustrated in Figure 18.3. Genetic heterogeneity exists for ANEC as shown in the Neilson et al. study, where four out of 16 familial cases did not harbor the RANBP2 mutation (Neilson et al., 2009). Other genes have been found to be associated with ANEC. A signicant association has been observed between the frequency of alleles DRB1*09:01 and DQB1*03:03 in ANEC patients compared to controls (Hoshino et al., 2016). ese genotypes are predominantly found within Japanese populations, potentially explaining the high incidence of ANEC in Japan.
 Infectious Disease and Neurocognition
Acute necrotizing encephalopathy
of childhood
RANBP2-positive
mutation
Other neurological
symptoms
Asymptomatic
Figure 18.3 The complex and overlapping relationships between the RANBP2 gene, influenza- associated encephalopathy, and acute necrotizing encephalopathy of childhood.
Influenza-associated
encephalopathy
Additionally, specic single- nucleotide polymorphisms in the CPTII gene, prima­rily reported within Asian populations, have also been identied as a risk factor for the development of ANEC (Shinohara et al., 2011).
Associated pathogens
Influenza
Inuenza is a respiratory virus associated with a range of neurological manifest­ations, such as febrile seizures and IAE. Both inuenza A and B have been reported in association with neurological symptoms, but inuenza A appears to be more fre­quently associated with neurological manifestations (Farooq et al., 2012). In a British study (2011– 2013) of inuenza- associated neurological manifestations, 84 per­cent (21/ 25) were attributed to inuenza A (95 percent (20 out of 21) H1N1), while four cases (16 percent) were linked to inuenza B (Goenka et al., 2014). In a 2- year Australian longitudinal study evaluating inuenza- associated neurological compli­cations (n = 54), seizures (30 percent, 16 out of 54) and febrile seizures (26 percent, 14 out of 54) were the two most common manifestations, with focal neurological symptoms being the least prevalent (6 percent, 3/ 54) (Britton et al., 2017). Specic encephalopathy syndromes associated with inuenza infection include mild en­cephalitis/ encephalopathy with a reversible splenial lesion, acute encephalopathy with biphasic seizures and late reduced diusion, and ANEC (Kasai et al., 2020). Regarding ANEC specically, inuenza accounted for 20 percent (eight out of 41) of cases in a retrospective study conducted in China (n = 41) and 41 percent (16 out of 39) in a Japanese national survey of acute encephalopathy (Hoshino et al., 2016;
Acute Necrotizing Encephalopathy of Childhood 285
Zhu et al., 2021). Compared to patients with IAE, two studies have identied that in­uenza associated with ANEC is more likely to exhibit elevated liver function tests (aspartate aminotransferase, alanine transaminase) and CSF pleocytosis (Liu et al., 2021; Song et al., 2021).
Severe acute respiratory syndrome coronavirus 2 infection
A wide range of neurological symptoms have been reported to be associated with se­vere acute respiratory syndrome coronavirus 2 (SARS- CoV- 2) infection. e symp­toms aect both the peripheral nervous system and CNS, with varying degrees of severity. e mechanism by which SARS- CoV- 2 leads to these diverse neurological syndromes is unknown. In 2021, Larovere and colleagues studied the neurolog­ical manifestations of hospitalized children and adolescents in the United States with SARS- CoV- 2 or multisystem inammatory syndrome and found that 22 per­cent (365 out of 1695) of cases had neurologic involvement (Larovere et al., 2021). Interestingly, no ANEC cases were reported (Larovere et al., 2021). Similar results were seen in another multinational study of patients in Canada, Iran, and Costa Rica (Yea et al., 2024).
A small number of reports of RANBP2- positive patients with SARS- CoV- 2 and ANEC exist. In 2023, Forest and colleagues reported a 10- year- old girl who tested positive for the RANBP2 mutation and developed ANEC in association with SARS­CoV- 2 infection (Forest et al., 2023). is child also had a prior ANEC episode at the time of an inuenza A infection at 2 years of age (Forest et al., 2023). Intriguingly, Virhammar and coworkers reported the isolation of SARS- CoV- 2 RNA in the CSF of an adult patient with ANEC associated with SARS- CoV- 2 symptoms, suggesting the possibility of neurotropism in the SARS- CoV- 2 virus itself (Virhammar et al.,
2020). In another case report, Bensaidane and colleagues reported an adult case of ANEC that occurred within 48 hours of receiving the ChAdOx1 nCoV- 19 vaccine (Bensaidane et al., 2022). Although the individual was found to have abnormalities in the RANBP2 mutation, the identied variant was due to an intronic change, and its pathogenic potential was thought to be low (Bensaidane et al., 2022). Other re­ports of ANEC in relation to SARS- CoV- 2 have not described an association with RANBP2 gene (Ho et al., 2023; Lazarte- Rantes et al., 2021).
Other associated pathogens
While ANEC has primarily been described in relation to inuenza and SARS- CoV­2 infections, other pathogens, primarily viruses, have been documented in ANEC cases. ese include rotavirus, enterovirus, adenovirus, parainuenza virus, HHV­6, human metapneumovirus, adenovirus, respiratory syncytial virus, dengue virus, herpes simplex virus, and mycoplasma (Abbas et al., 2017; Chatur et al., 2022;
 Infectious Disease and Neurocognition
Fan et al., 2022; Huber et al., 2020; Kumar et al., 2021; Otake et al., 2023; Poojari et al., 2021; Stevanovic et al., 2019; Tabarki et al., 2013). Notably, certain bacterial pathogens, including Streptococcus pneumoniae, Escherichia coli, and Neisseria gonorrhoeae, have also been reported (Huber et al., 2020; Wang et al., 2021). Interestingly, there are no clear dierences in terms of clinical presentation in rela­tion to the dierent pathogens.
Clinical manifestations
e earliest reports of clinical manifestations of ANEC cases were described prior to knowledge about familial/ genetic cases of ANEC. In these descriptive reports, aected children presented with prodromal symptoms resembling viral infections, such as respiratory tract or gastrointestinal symptoms. Following a period of 1– 5 days, neurological symptoms were seen to emerge, including fever, altered con­sciousness, and seizures (Mizuguchi, 1997; Mizuguchi et al., 1995). Additionally, various degrees of involvement of other organs were described in these early co­horts, including hemodynamic instability, elevated liver enzyme levels, increased lactate dehydrogenase concentrations, elevated creatine kinase levels, and throm­bocytopenia (Aksoy et al., 2021; Wu et al., 2022; Zhu et al., 2021). e presence of transaminitis ranged from 12 percent to 77 percent of cases (Aksoy et al., 2021; Jan et al., 2019; Wu et al., 2022). CSF pleocytosis was reported in 12– 30 percent of cases in various studies (Chatur et al., 2022; Neilson et al., 2003). Elevation of CSF protein (> 0.4 g/ L) was found in 55– 83 percent of cases (Aksoy et al., 2021; Chatur et al., 2022; Fan et al., 2022). One study showed abnormal electroencephalogram results in all reported cases, although this has not been conrmed in other studies (Fan et al.,
2022). In this study, 83.3 percent (ten out of 12) of patients exhibited diuse slowing on electroencephalography, while the remaining cases showed asynchronous spike waves (Fan et al., 2022).
It is not clear if the clinical syndrome in RANBP2- positive children with ANEC (or ANE1) diers from those who are RANBP2 negative. As noted above, outside of increased risk for recurrence, few dierences between those with ANEC who were RANBP2 positive and RANBP2 negative were seen in one study (Chatur et al., 2022). In 2023, Sarigecili and colleagues described nine pediatric patients with ANEC, all of whom tested positive for the RANBP2 gene (Sarigecili et al., 2023). Among these patients, four out of nine had a history of previous attacks with a similar phenotype. Encephalopathy occurred in all cases, with seizures occurring in 44 percent (four out of nine) of patients, ataxia in 11 percent (one out of nine), and monoplegia in 11 percent (one out of nine) (Sarigecili et al., 2023).
e visual pathway may be aected in this population. In the Sarigecili et al. se­ries, 33 percent (three out of nine) of patients experienced acute vision problems including blurred vision and visual loss (Sarigecili et al., 2023). Similarly, Chew and Ngu’s report of three RANBP2- positive siblings in a Malaysian family demonstrated
Acute Necrotizing Encephalopathy of Childhood 287
two with visual symptoms, including one with blurred vision and impaired color vi­sion and another with visual loss (Chew & Ngu, 2020). Of note, regarding laboratory investigations, the majority of patients in RANBP2- positive cases do not appear to have hepatic involvement, as indicated by normal liver enzyme levels in 78 percent (seven out of nine) of the RANBP2- positive cases reported by Sarigecili et al. (2023).
Radiographic findings
e initial 1995 case series rst describing ANEC, a time when MRI was less widely available, demonstrated imaging ndings including multiple hypodense lesions in a symmetrical pattern on computed tomography scans of the brain, with the common unifying feature of bilateral thalamic lesions (Mizuguchi et al., 1995). Notably, this was an imaging- based description based on pattern recognition. Bilateral involve­ment of the thalami has remained a distinctive feature of ANEC. However, other areas of focal involvement have been described, including the periventricular white matter, brainstem, basal ganglia, cerebral cortex and subcortex, and cerebellum (Wong et al., 2006; Zhu et al., 2021). It is important to note that results of genetic testing were not reported in the patients described in these cases.
In the acute stage, the aected areas appear hypointense on T1- weighted im­aging and hyperintense on T2/ uid- attenuated inversion recovery- weighted MRI sequences. Hemorrhage, cavitation, and contrast enhancement may also be seen (Wong et al., 2006). e imaging features are dynamic: early scans may be within normal limits, with progression to marked swelling of the thalami over the course of a 24- hour period (Yoshida et al., 2013). Notably, the study by Chatur and col­leagues found that the presence of hemorrhagic lesions on MRI was associated with inuenza A infection and were not limited to those who were positive for the RANBP2 gene mutation (Chatur et al., 2022). Furthermore, no dierences in im­aging regarding the degree of thalamic swelling, thalamic hemorrhage, or the extent of diusion restriction between patients with positive RANBP2 and those without were seen in this study (Chatur et al., 2022). In another study, Neilson and colleagues found that in familial cases (ANE1), other CNS structures were frequently involved, specically the external capsule, claustrum, limbic structures, or temporal lobes (Neilson et al., 2009).
Other MRI modalities have elucidated other features, including metabolic changes and the evolution of acute brain changes in ANEC. Magnetic resonance spectroscopy of lesions has shown high choline and inverted lactate peaks. Diusion- weighted MRI has revealed the specic nding of a trilaminar pattern in the thalamus during the acute stage, specically showing a center core in the thalamus with a higher ap­parent diusion coecient (ADC) than the normal parenchyma (Albayram et al.,
2004). e high ADC core in the thalamus is correlated with the presence of subacute hemorrhagic lesions observed on the follow- up MRI (Albayram et al., 2004). e periphery of the core displays very low ADC and high diusion- weighted imaging